Schrodinger Operating Margin 2019-2025 | SDGR
Current and historical operating margin for Schrodinger (SDGR) over the last 10 years. The current operating profit margin for Schrodinger as of March 31, 2025 is -76.22%.
| Schrodinger Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $0.23B | $-0.19B | -83.91% |
| 2024-12-31 | $0.21B | $-0.21B | -100.97% |
| 2024-09-30 | $0.19B | $-0.22B | -112.95% |
| 2024-06-30 | $0.20B | $-0.21B | -102.49% |
| 2024-03-31 | $0.19B | $-0.21B | -113.23% |
| 2023-12-31 | $0.22B | $-0.18B | -82.03% |
| 2023-09-30 | $0.20B | $-0.18B | -88.50% |
| 2023-06-30 | $0.19B | $-0.17B | -86.08% |
| 2023-03-31 | $0.20B | $-0.15B | -75.63% |
| 2022-12-31 | $0.18B | $-0.15B | -81.22% |
| 2022-09-30 | $0.17B | $-0.14B | -82.94% |
| 2022-06-30 | $0.16B | $-0.13B | -79.75% |
| 2022-03-31 | $0.16B | $-0.12B | -75.48% |
| 2021-12-31 | $0.14B | $-0.11B | -81.16% |
| 2021-09-30 | $0.13B | $-0.11B | -84.80% |
| 2021-06-30 | $0.12B | $-0.09B | -71.07% |
| 2021-03-31 | $0.11B | $-0.07B | -64.04% |
| 2020-12-31 | $0.11B | $-0.06B | -56.48% |
| 2020-09-30 | $0.10B | $-0.05B | -51.49% |
| 2020-06-30 | $0.10B | $-0.05B | -50.53% |
| 2020-03-31 | $0.09B | $-0.05B | -49.45% |
| 2019-12-31 | $0.09B | $-0.04B | -45.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.367B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.259B | 57.58 |
| Doximity (DOCS) | United States | $11.613B | 51.53 |
| Hims & Hers Health (HIMS) | United States | $11.187B | 92.56 |
| Tempus AI (TEM) | United States | $10.529B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.158B | 0.00 |
| Hinge Health (HNGE) | United States | $4.347B | 0.00 |
| Privia Health (PRVA) | United States | $2.493B | 184.64 |
| Inspire Medical Systems (INSP) | United States | $2.355B | 34.62 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.607B | 8.49 |
| 10x Genomics (TXG) | United States | $1.516B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Azenta (AZTA) | United States | $1.283B | 55.96 |
| Clover Health Investments (CLOV) | United States | $1.257B | 0.00 |
| Evolent Health (EVH) | United States | $1.082B | 0.00 |
| Claritev (CTEV) | United States | $1.013B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.631B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Standard BioTools (LAB) | United States | $0.486B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.461B | 0.00 |
| Talkspace (TALK) | United States | $0.412B | 123.00 |
| Carlsmed (CARL) | $0.346B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.342B | 0.00 |
| TruBridge (TBRG) | United States | $0.288B | 50.50 |
| Nyxoah SA (NYXH) | Belgium | $0.239B | 0.00 |
| Outset Medical (OM) | United States | $0.221B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| CapsoVision (CV) | United States | $0.190B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.188B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.108B | 4.92 |
| EUDA Health Holdings (EUDA) | Singapore | $0.094B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |